Amy White

The human disease network

Removing T-cell epitopes with computational protein design

Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report

Drug delivery to peroxisomes: Employing unique trafficking mechanisms to target protein therapeutics☆

The Role of the Endoplasmic Reticulum in Peroxisome Biogenesis

Beyond humanization and de-immunization: tolerization as a method for reducing the immunogenicity of biologics

Maximizing the Adequacy of Medication Treatment in Controlled Trials and Clinical Practice: STAR*D Measurement-Based Care

Strategies in the design of nanoparticles for therapeutic applications

Adeno-associated virus vector as a platform for gene therapy delivery

Peroxisome biogenesis disorders

The role of immune tolerance induction in restoration of the efficacy of ERT in Pompe disease

Adeno-Associated Virus Gene Therapy for Liver Disease

Pharmacotherapy of Pompe disease

In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism

Antidrug Antibody Formation in Oncology: Clinical Relevance and Challenges

A vesicle carrier that mediates peroxisome protein traffic from the endoplasmic reticulum

Peroxisome biogenesis disorders: Biological, clinical and pathophysiological perspectives

Peroxisome Biogenesis Disorders

Natural product and natural product derived drugs in clinical trials

Unique double-ring structure of the peroxisomal Pex1/Pex6 ATPase complex revealed by cryo-electron microscopy

Natural history of rhizomelic chondrodysplasia punctata

Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe disease

Long-Term Costs of Treatment for Depression: Impact of Drug Selection and Guideline Adherence